Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Clinical trial NCT04598542 · COMPLETED
Trial details
- NCT number
- NCT04598542
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2020-12-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.